Literature DB >> 9576221

Techniques and results in the management of multiple ventricular septal defects.

T Kitagawa1, L A Durham, R S Mosca, E L Bove.   

Abstract

OBJECTIVE: The management of patients with multiple ventricular septal defects remains controversial. Primary closure, interventional catheter techniques, and palliative surgery all may have a role, and specific management guidelines remain undefined.
METHODS: We reviewed the records of all 33 patients with multiple ventricular septal defects undergoing repair between January 1988 and October 1996. Pulmonary artery hypertension was present in 21 patients (group 1), and pulmonary stenosis was present in the remaining 12 (group 2). Closure was accomplished from a right atriotomy alone in most patients, although an apical left ventriculotomy was used for apical defects. Among group 1 patients, the mean age at repair was 5.9 +/- 0.9 months. Major associated anomalies included coarctation (n = 6), straddling tricuspid valve (n = 1), and critical aortic stenosis (n = 1). Reoperation was performed in two patients for residual ventricular septal defects. Among group 2 patients, the mean age at repair was 6.6 +/- 3.2 years. Major associated anomalies included tetralogy of Fallot (n = 2), pulmonary stenosis (n = 4), double-outlet right ventricle with hypoplastic left ventricle (n = 1), and isolated left ventricular hypoplasia (n = 1). Three required reoperation for residual ventricular septal defect.
RESULTS: There were no early or late deaths, no episodes of heart block, and no significant residual ventricular septal defects among group 1 patients. All group 1 patients remain free of significant residual cardiovascular conditions at a mean of 23.4 +/- 5.1 months. Among group 2 patients, there was one early death in a patient with double-outlet right ventricle and left ventricular hypoplasia. Complete heart block occurred in two patients and one required late mitral valve replacement. There were no late deaths, seven remain alive without significant residual defects at a mean of 36.2 +/- 8.0 months, and two required transplantation for left ventricular failure.
CONCLUSIONS: Primary repair for infants with multiple ventricular septal defects is associated with good late outcomes. The right atrial approach is satisfactory for most muscular defects, although limited apical left ventriculotomy was used for apical defects. Pulmonary artery banding should be limited to patients with complex associated defects.

Entities:  

Mesh:

Year:  1998        PMID: 9576221     DOI: 10.1016/S0022-5223(98)70366-6

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  21 in total

Review 1.  Surgical management of muscular trabecular ventricular septal defects.

Authors:  Toshihide Asou
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-11-15

Review 2.  Catheter closure of congenital muscular ventricular septal defects.

Authors:  B D Thanopoulos
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

3.  Hybrid pediatric cardiac surgery.

Authors:  E A Bacha; Z M Hijazi; Q-L Cao; R Abdulla; J P Starr; J Quinones; P Koenig; B Agarwala
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

Review 4.  Current topics in surgery for multiple ventricular septal defects.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Yoshinori Doki; Katsunori Takeuchi; Tomonori Higuma; Kazutaka Senda; Masayoshi Toge; Tatsuro Matsuo; Saori Nagura; Masaya Aoki; Kimimasa Sakata; Mari Sakai
Journal:  Surg Today       Date:  2015-05-03       Impact factor: 2.549

Review 5.  Utilizing Hybrid Techniques to Maximize Clinical Outcomes in Congenital Heart Disease.

Authors:  David W Bearl; Gregory A Fleming
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

6.  Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder.

Authors:  B D Thanopoulos; M L Rigby
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

7.  Multicenter experience with perventricular device closure of muscular ventricular septal defects.

Authors:  E A Bacha; Q L Cao; M E Galantowicz; J P Cheatham; C E Fleishman; S W Weinstein; P A Becker; S L Hill; P Koenig; E Alboliras; R Abdulla; J P Starr; Z M Hijazi
Journal:  Pediatr Cardiol       Date:  2005 Mar-Apr       Impact factor: 1.655

8.  Percutaneous Ventricular Septal Defect Closure in Patients Under 1 Year of Age.

Authors:  Nazmi Narin; Ozge Pamukcu; Aydin Tuncay; Ali Baykan; Suleyman Sunkak; Onur Tasci; Kazim Uzum; Levent Saltık
Journal:  Pediatr Cardiol       Date:  2018-03-15       Impact factor: 1.655

9.  Perventricular device closure of isolated muscular ventricular septal defect in infants: a single centre experience.

Authors:  Bhavesh Thakkar; Nehal Patel; Shaunak Shah; Vishal Poptani; Tarun Madan; Chirag Shah; Anand Shukla; Vaishali Prajapati
Journal:  Indian Heart J       Date:  2012-09-12

10.  Perventricular closure of muscular ventricular septal defects: How do I do it?

Authors:  Karim A Diab; Qi-Ling Cao; Ziyad M Hijazi
Journal:  Ann Pediatr Cardiol       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.